Title: Pre- Budget Hearing 2018
Date: Wednesday, 14th February 2018 – Corporate sector
Thursday, 15th February 2018 – Social Sector
Time: 8.00am - 11.30am (Both Days.)
Venue: Sarova Stanley Hotel, Nairobi
The Public are invited to attend...
|Post Date: 22 February 2018 | Category: General | Hits: 233|
Ministry of Health estimates that over 1.5 million Kenyans are living with HIV by 2015 with the prevalence rate of 5.6% having declined from 5.7% a year earlier. Statistics on the prevalence rates show that HIV in Kenya is on the decline. The effort by the government effort to provide antiretroviral therapy is also being enhanced, for instance since 2000, the coverage has increased rapidly to over 60% by 2016.
In this week’s number of the week we examine the effect of introduction of ART drugs to HIV prevalence in Kenya. Is there any impact on HIV prevalence with the introduction of antiretroviral therapy?
The chart below is a scatter plot of prevalence of HIV, total (% of population ages 15-49) against antiretroviral therapy coverage (% of people living with HIV). The chart illustrates changes in HIV prevalence against changes in the ART.
Chart 1: HIV Prevalence against ART coverage
Source: World Bank –World Development Indicators
The chart reveals indirect relationship between HIV prevalence and ART. It shows that HIV prevalence has been declining exponentially with increase in ART coverage to HIV patients. In 2000, HIV prevalence was
10.2%, in 2010 the rate had reduced to 6.1%, while the latest statistic show that the rate is 5.4% in 2016.
Number of the week: 4.8 percentage points
Budget Utilization Rates in the Ministry of Health.
Gross Budgeted Expenditure and Revenue Collection 2011-2016.
Impact of antiretroviral therapy on prevalence of HIV in Kenya.
Quantities of Principal Domestic Exports - Cement (2012-2016).